medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2006, Number 4

<< Back Next >>

Rev Mex Oftalmol 2006; 80 (4)

Catarata en pacientes con trisomía 21

Ruiz-Quintero NC, Villanueva-Mendoza C

Language: Spanish
References: 39
Page: 180-184
PDF size: 77.12 Kb.


ABSTRACT

Purpose: To determinate the clinical characteristics and therapy of cataracts in patients with trisomy 21.
Materials and methods: A retrospective, descriptive, analytic and longitudinal study was realized. Patients with diagnosis of trisomy 21 and cataract were examined from March 1990 to March 2001. The clinical characteristics were grouped in a data base in order to realize further descriptive analysis and statistics.
Results: We studied 28 patients with Down syndrome and cataract (49 eyes), 18 (64.28%) males and 10 (35.71%) females, of ages between 6 months and 53 years. They presented unilateral cataract in 25% and bilateral in 75%. Congenital cataract was the most frequent one. All patients underwent surgery. The surgical technique used was phacoemulsification with intraocular lens implantation in almost every case.
Conclusions: The patients with trisomy 21 that presented cataract were detected during the first decade of life. The congenital variety, with a specific morphology, was the most frequent one. In almost every case a total opacity or pulvurulent cataract was found. The most often used surgical technique was phacoaspiration with intraocular lens implantation.


REFERENCES

  1. Warburg M, Andersen SR. Ocular changes in simple trisomy and in a few cases of partial trisomy. North Am Cl; 372-383.

  2. Bromham NR, Woodhouse JM, Cregg M. Heart defects and ocular anormalies in children with Down’s syndrome. Brit J Ophthalmol 2002; 86:1367-1368.

  3. Catalano RB. Down syndrome. Surv Ophthalmol 1990; 34:385-395.

  4. Dastgiri S, Gilmore WH, Stone DH. Survival of children born with congenital anormalies. Arch Dis Child 2003; 88:391-394.

  5. Haugen OH, Hovding G, Riise R. Ocular changes in Down syndrome. Tidsskr Nor Laegeforen. 2004;124(2):186-8.

  6. Chung CS, Myrianthopoulos NC. Factors affecting risks of congenital malformations. I. Analysis of epidemiologic factors in congenital malformations. Report from the Collaborative Perinatal Project. Birth Defects Orig Artic Ser 1975; 11(10):1-22.

  7. Robb RM, Marchevsky A. Pathology of the lens in Down’s syndrome. Arch Ophthalmol 1978; 96:1039-1042.

  8. Gnad HD, Rett A. Ocular signs in cases of Down’s syndrome (author’s transl). Wien Klin Wochenschr 1979; 91(21):735-7.

  9. Rabinowitz YS. Keratoconus. Surv Ophthalmol 1998; 42:297-319.

  10. Perez-Carpinell J, de Fez MD, Climent V. Vision evaluation in people with Down’s syndrome. Ophthalmic Physiol Opt 1994; 14(2):115-21.

  11. Caputo AR, Wagner RS, Reynolds DR. Down syndrome. Clinical review of ocular features. Clin Pediatr (Phil) 1989; 28(8):355-8.

  12. Pires de Cunha R, De Castro MJ. Ocular findings in Down’s syndrome. Am J Ofhthalmol 1996; 122:236-244.

  13. Kim JH, Hwang JM, Kim HJ. Characteristic ocular findings in Asian children with Down syndrome. Eye 2002; 16(6):710-4.

  14. Gonzalez Viejo I, Ferrer Novel C, Ferrer Novella E. Ophthalmological exploration of children with Down’s syndrome. Main results and comparison with a control group. An Esp Pediatr 1996; 45(2):137-9.

  15. Pires de Cunha RP, Moreira JB. Ocular findings in Down’s syndrome. Am J Ophthalmol 1996; 122(2):236-44.

  16. Berk AT, Saatci AO, Ercal MD. Ocular findings in 55 patients with Down’s syndrome. Ophthalmic Genet 1996; 17(1):15-9.

  17. Robb RM, Marchevsky A. Pathology of the lens in Down’s syndrome. Arch Ophthalmol 1978; 96(6):1039-42.

  18. Jaeger EA. Ocular findings in Down’s syndrome. T Am Ophthalmol Soc 1980; 78:808-45.

  19. Reddy VN, Giblin FJ, Lin LR. Glutathione peroxidase-1 deficiency leads to increased nuclear light scattering, membrane damage, and cataract formation in gene-knockout mice. Inv Ophthal Vis Sci 2001; 42:3247-3255.

  20. Frederikse PH, Ren XO. Lens defects and age-related fiber cell degeneration in a mouse model of increased ABPP gene dosage in Down syndrome. Am J Pathol 2002; 161:1985-1990.

  21. Ruotolo R, Grassi F, Percudani R. Gene expression profiling in human age-related nuclear cataract. Molec Vis 2003; 9:538-548.

  22. Cengiz M, Seven M, Suyugul N. Antioxidant system in Down syndrome: a possible role in cataractogenesis. Genet Couns 2002; 13(3):339-42.

  23. Romain M, Awoust J, Dugauquier C, Van Maldergem L. Prenatal ultrasound detection of congenital cataract in trisomy 21. Prenat Diagn 1999; 19:780-782.

  24. Mohan M, Bartholomew S. Spontaneous absorption of a cataractous lens. Act Ophthalmol Scand 1999; 77:476-477.

  25. Keefe M, Mulvihill A, Yeoh PL. Visual outcome and complications of bilateral intraocular lens implantation in children. J Cataract Refract Surg 2000; 26:1758-1764.

  26. Koraszewska-Matuszewska B, Pieczara E, Samochowiec-Donocik E. Ocular changes in Down’s syndrome. Klin Oczna 1994; 96(6-7):239-41.

  27. Goto S, Yo M, Hayashi T. Intraocular lens implantation in severely mentally and physically handicapped patients. Jpn J Ophthalmol. 1995; 39(2):187-92.

  28. Sheppard RW, Crawford JS. The treatment of congenital cataracts. Surv Ophthalmol 1973; 17:340-347.

  29. Toyofuku K, Hirose T Schepens CL. Retinal detachment following congenital cataract surgery. Arch Ophthalmol 1980; 98:669-675.

  30. Traboulsi E, Levine E, Mets MB. Infantile glaucoma in Down’s syndrome (Trisomy 21). Am J Ophthalmol 1988; 105:389-394.

  31. Ginsberg J, Bofinger MK, Roush JR. Pathologic features of the eye in Down’s syndrome with relationship to other chromosomal anomalies. Am J Ophthalmol 1977; 83(6):874-80.

  32. Bras A, Monteiro C, Rueff J. Oxidative stress in trisomy 21. A possible role in cataractogenesis. Ophhalmic Paediatr Genet 1989; 10:272-277.

  33. Roizen NJ, Mets MB, Blondis TA. Ophthalmic disorders in children with Down syndrome. Dev Med Child Neurol 1994; 36(7):594-600.

  34. Woodhouse JM, Cregg Mary, Gunter HL y col. The effect of age, size of target, and cognitive factors on accommodative responses of children with Down syndrome. Inv Ophthal Vis Sci 2000; 41:2479-2485.

  35. Cregg M, Woodhouse VH, Saunders KJ. Accommodation and refractive error in children with Down syndrome: Crosssectional and longitudinal studies. Inv Ophthal Vis Sci 2001;42:55-63.

  36. Jonelid B, Anneren G, Holmstrom G. Children and adolescents with Down syndrome. Continuous ophthalmological monitoring crucial! Lakartidningen 2002; 99(1-2):29-32.

  37. van Wouwe JP, Siderius EJ, Borstlap R. Optimal medical care for children with Down syndrome and their parents. Ned Tijdschr Geneeskd 2001; 145(34):1617-21.

  38. Shapiro MB, France TD. The ocular features of Down’s syndrome. Am J Ophthalmol 1995; 99:659-663.

  39. Woodhouse JM, Meades JS, Leat SJ y col. Reduced accommodation in children with Down syndrome. Inv Ophthal Vis Sci 1993; 34:2382-2387.




2020     |     www.medigraphic.com